Kino T, Chrousos GP. Glucocorticoid effects on gene expression. Steckler T, Kalin NH , Reul JMHM, eds. Handbook of Stress and the Brain. Amsterdam: Elsevier; 2005. 5(1): 295–311.
Chrousos GP, Charmandari E, Kino T. Glucocorticoid action networks--an introduction to systems biology. J Clin Endocrinol Metab. 2004 Feb. 89(2):563-4. [QxMD MEDLINE Link].
Chrousos GP. The glucocorticoid receptor gene, longevity, and the complex disorders of Western societies. Am J Med. 2004 Aug 1. 117(3):204-7. [QxMD MEDLINE Link].
Galon J, Franchimont D, Hiroi N, et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 2002 Jan. 16(1):61-71. [QxMD MEDLINE Link].
Zhou J, Cidlowski JA. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids. 2005 May-Jun. 70(5-7):407-17. [QxMD MEDLINE Link].
Duma D, Jewell CM, Cidlowski JA. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol. 2006 Dec. 102(1-5):11-21. [QxMD MEDLINE Link].
Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids. 2010 Jan. 75(1):1-12. [QxMD MEDLINE Link].
Hollenberg SM, Weinberger C, Ong ES, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 1985 Dec 19-1986 Jan 1. 318(6047):635-41. [QxMD MEDLINE Link].
Kino T, Manoli I, Kelkar S, Wang Y, Su YA, Chrousos GP. Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. Biochem Biophys Res Commun. 2009 Apr 17. 381(4):671-5. [QxMD MEDLINE Link].
Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J Biol Chem. 1999 Sep 24. 274(39):27857-66. [QxMD MEDLINE Link].
Chrousos GP, Kino T. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE. 2005 Oct 4. 2005(304):pe48. [QxMD MEDLINE Link].
McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 1999 Jun. 20(3):321-44. [QxMD MEDLINE Link].
McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 2002 Feb 22. 108(4):465-74. [QxMD MEDLINE Link].
Auboeuf D, Honig A, Berget SM, O'Malley BW. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science. 2002 Oct 11. 298(5592):416-9. [QxMD MEDLINE Link].
Hittelman AB, Burakov D, Iniguez-Lluhi JA, Freedman LP, Garabedian MJ. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J. 1999 Oct 1. 18(19):5380-8. [QxMD MEDLINE Link].
Liu J, DeFranco DB. Protracted nuclear export of glucocorticoid receptor limits its turnover and does not require the exportin 1/CRM1-directed nuclear export pathway. Mol Endocrinol. 2000 Jan. 14(1):40-51. [QxMD MEDLINE Link].
Chrousos GP. Hormone resistance and hypersensitivity rtates. Chrousos GP, Olefsky JM, Samols E. (eds). Modern Endocrinology Series. Philadelphia, PA: Lippincott, Williams & Wilkins; 2002. 318(6047): 542.
Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP. Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol. 2003 Jun. 85(2-5):457-67. [QxMD MEDLINE Link].
Chrousos GP, Kino T. Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann N Y Acad Sci. 2009 Oct. 1179:153-66. [QxMD MEDLINE Link].
Chrousos GP, Vingerhoeds A, Brandon D, et al. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest. 1982 Jun. 69(6):1261-9. [QxMD MEDLINE Link]. [Full Text].
Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med. 1993 Dec 1. 119(11):1113-24. [QxMD MEDLINE Link].
Charmandari E, Kino T, Ichijo T, Chrousos GP. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab. 2008 May. 93(5):1563-72. [QxMD MEDLINE Link].
Nader N, Bachrach BE, Hurt DE, et al. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain. J Clin Endocrinol Metab. 2010 May. 95(5):2281-5. [QxMD MEDLINE Link].
McMahon SK, Pretorius CJ, Ungerer JP, et al. Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J Clin Endocrinol Metab. 2010 Jan. 95(1):297-302. [QxMD MEDLINE Link].
Tomlinson JW, Walker EA, Bujalska IJ, et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 2004 Oct. 25(5):831-66. [QxMD MEDLINE Link].
Charmandari E, Kino T. Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. Eur J Clin Invest. 2010 Oct. 40(10):932-42. [QxMD MEDLINE Link].
Chrousos G. Q&A: primary generalized glucocorticoid resistance. BMC Med. 2011 Mar 23. 9:27. [QxMD MEDLINE Link].
Karl M, Lamberts SW, Koper JW, et al. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians. 1996 Jul. 108(4):296-307. [QxMD MEDLINE Link].
Hurley DM, Accili D, Stratakis CA, et al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest. 1991 Feb. 87(2):680-6. [QxMD MEDLINE Link].
Karl M, Lamberts SW, Detera-Wadleigh SD, et al. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab. 1993 Mar. 76(3):683-9. [QxMD MEDLINE Link].
Malchoff DM, Brufsky A, Reardon G, et al. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest. 1993 May. 91(5):1918-25. [QxMD MEDLINE Link].
Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab. 2001 Nov. 86(11):5600-8. [QxMD MEDLINE Link].
Ruiz M, Lind U, Gafvels M, et al. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf). 2001 Sep. 55(3):363-71. [QxMD MEDLINE Link].
Mendonca BB, Leite MV, de Castro M, et al. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab. 2002 Apr. 87(4):1805-9. [QxMD MEDLINE Link].
Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab. 2002 Jun. 87(6):2658-67. [QxMD MEDLINE Link].
Charmandari E, Kino T, Souvatzoglou E, Vottero A, Bhattacharyya N, Chrousos GP. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. J Clin Endocrinol Metab. 2004 Apr. 89(4):1939-49. [QxMD MEDLINE Link].
Charmandari E, Raji A, Kino T, et al. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab. 2005 Jun. 90(6):3696-705. [QxMD MEDLINE Link].
Charmandari E, Kino T, Ichijo T, Zachman K, Alatsatianos A, Chrousos GP. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance. J Clin Endocrinol Metab. 2006 Apr. 91(4):1535-43. [QxMD MEDLINE Link].
Charmandari E, Kino T, Ichijo T, et al. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab. 2007 Oct. 92(10):3986-90. [QxMD MEDLINE Link].
Zhu HJ, Dai YF, Wang O, et al. Generalized glucocorticoid resistance accompanied with an adrenocortical adenoma and caused by a novel point mutation of human glucocorticoid receptor gene. Chin Med J (Engl). 2011 Feb. 124(4):551-5. [QxMD MEDLINE Link].
Roberts ML, Kino T, Nicolaides NC, et al. A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD. J Clin Endocrinol Metab. 2013 Apr. 98(4):E790-5. [QxMD MEDLINE Link].
Nicolaides NC, Roberts ML, Kino T, et al. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities. J Clin Endocrinol Metab. 2014 May. 99(5):E902-7. [QxMD MEDLINE Link].
Nicolaides NC, Geer EB, Vlachakis D, et al. A novel mutation of the hGR gene causing Chrousos syndrome. Eur J Clin Invest. 2015 Aug. 45(8):782-91. [QxMD MEDLINE Link].
Nicolaides NC, Skyrla E, Vlachakis D, et al. Functional characterization of the hGRαT556I causing Chrousos syndrome. Eur J Clin Invest. 2016 Jan. 46(1):42-9. [QxMD MEDLINE Link].
Nicolaides NC, Charmandari E. Chrousos syndrome: from molecular pathogenesis to therapeutic management. Eur J Clin Invest. 2015 May. 45(5):504-14. [QxMD MEDLINE Link].
Vitellius G, Trabado S, Hoeffel C, et al. Significant prevalence of NR3C1 mutations in incidentally discovered bilateral adrenal hyperplasia: results of the French MUTA-GR Study. Eur J Endocrinol. 2018 Apr. 178 (4):411-23. [QxMD MEDLINE Link].
Nicolaides NC, Chrousos GP. Bilateral adrenal hyperplasia and NR3C1 mutations causing glucocorticoid resistance: Is there an association?. Eur J Endocrinol. 2018 Oct 12. 179 (5):C1-C4. [QxMD MEDLINE Link].
Nicolaides NC, Charmandari E. Primary generalized glucocorticoid resistance and hypersensitivity syndromes: a 2021 update. Int J Mol Sci. 2021 Oct 7. 22 (19):[QxMD MEDLINE Link]. [Full Text].